comparemela.com
  1. Home
  2. Live Updates
  3. Pallav Shah - Breaking News

Latest Breaking News On - Pallav shah - Page 13 : comparemela.com

Persistent Breathlessness After COVID-19 May Be Caused by Ongoing Immune Injuries

According to a study, long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.

Pallav shahJames harkerBavithra vijayakumarImperial national heart lung instituteNational heart lung instituteNational heartLung instituteProfessor pallav shah

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.

United kingdomCity ofPallav shahJames harkerBavithra vijayakumarEmily hendersonLung instituteImperial college londonImperial national heart lung instituteDepartment of immunologyCommunity jameelNational heartWestminster medical school researchJoint lead authorProfessor pallav shahWellcome trust

Ongoing immune injuries might cause persistent breathlessness after Covid

Ongoing immune injuries might cause persistent breathlessness after Covid
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofPallav shahJames harkerBavithra vijayakumarDr james harker national heart lung instituteLung instituteProfessor pallav shah national heart lung instituteImperial college londonImperial national heart lung instituteDepartment of immunologyCommunity jameelNational heartWestminster medical school researchJames harker national heartProfessor pallav shah

200th Treatment Milestone for AIRFLOW-3 COPD Trial

/PRNewswire/ Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones. 200 patients have.

United statesUnited kingdomCity ofPallav shahPrnewswire nuvairaGerard crinerProfessor of respiratory medicine at imperial collegeNuvaira incInnovatus capital partnersTreated worldwideTargeted lung denervationThoracic medicineLewis katz schoolTemple universityConsultant physicianRoyal brompton hospitals

200th Treatment Milestone for AIRFLOW-3 COPD Trial

/PRNewswire/ Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones. 200 patients have.

United statesUnited kingdomCity ofPallav shahPrnewswire nuvairaGerard crinerProfessor of respiratory medicine at imperial collegeNuvaira incInnovatus capital partnersTreated worldwideTargeted lung denervationThoracic medicineLewis katz schoolTemple universityConsultant physicianRoyal brompton hospitals

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.